The Role of Antiangiogenetic Agents in the Treatment of Breast Cancer
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
5022-5032
Author(s):
M. A. Bareschino, C. Schettino, G. Colantuoni, E. Rossi, A. Rossi, P. Maione, F. Ciardielloi and C. Gridell
Cytokines as Anti-Angiogenic Agents in Haematological Malignancies
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
997-1004
Author(s):
C. Cocco, E. Ferretti, I. Airoldi and V. Pistoia
Emerging Therapies Targeting Tumor Vasculature in Multiple Myeloma and other Hematologic and Solid Malignancies
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
1005-1024
Author(s):
K. Podar and K. C. Anderson
Clinical Experience with Antiangiogenic Therapy in Leukemia
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
1053-1068
Author(s):
J. Wellbrock and W. Fiedler
EphA2-Dependent Molecular Targeting Therapy for Malignant Tumors
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
1082-1097
Author(s):
RONG Biao-xue, CAI Xi-guang, YANG Shuan-ying, LI Wei and MING Zong-juan
Hepatoma-Derived Growth Factor in Carcinogenesis and Cancer Progression
Journal:
Current Drug Therapy
Volume:
6
Page:
278-285
Author(s):
Hideji Nakamura and Hirayuki Enomoto
Key Questions in Metastasis: New Insights in Molecular Pathways and Therapeutic Implications
Journal:
Current Pharmaceutical Biotechnology
Volume:
12
Page:
1867-1880
Author(s):
G. Gueron, A. De Siervi and E. Vazquez
Metastatic Cancer Stem Cells: New Molecular Targets for Cancer Therapy
Journal:
Current Pharmaceutical Biotechnology
Volume:
12
Page:
1909-1922
Author(s):
G. J. Leiros and M. E. Balana
Tumor Immune Escape Mechanisms that Operate During Metastasis
Journal:
Current Pharmaceutical Biotechnology
Volume:
12
Page:
1923-1936
Author(s):
D. O. Croci and M. Salatino
Role of MMPs in Metastatic Dissemination: Implications for Therapeutic Advances
Journal:
Current Pharmaceutical Biotechnology
Volume:
12
Page:
1937-1947
Author(s):
D. Raffo, O. Pontiggia and M. Simian